Cripto: A novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia

BioEssays

Volumn 21, Issue 1, 1999, Pages 61-70

  Salomon, David S ^a   Bianco, Caterina ^a   De Santis, Marta ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MEMBRANE PROTEIN; TDGF1 PROTEIN, HUMAN; TDGF1 PROTEIN, MOUSE; TUMOR MARKER; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; BREAST; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; REVIEW; SEQUENCE ALIGNMENT; UDDER;

AMINO ACID SEQUENCE; ANIMALS; BREAST; BREAST NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PREGNANCY; SEQUENCE ALIGNMENT; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0032967278     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199901)21:1<61::AID-BIES8>3.0.CO;2-H     Document Type: Review

References (71)

1. Medina D. The mammary gland: a unique organ for the study of development and tumorigenesis. J Mamm Gland Biol Neoplasia 1996;1: 5-19.
2. Groenen LC, Nice EC, Burgess AW. Structure-function relationships for the EGF/TGF-α family of mitogens. Growth Factors 1994;11:235-257.
3. Chang H, Riese DJ II, Gilbert W, Stern DF, McMahan UJ. Ligands for Erb-family receptors encoded by a neuregulin-like gene. Nature 1997;387: 509-512.
4. Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, Hillan K, Crowley C, Brush J, Godowski PJ. Neuregulin-3 (NRG-3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 1997;94:9562-9567.
5. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995;19:183-232.
6. Mason S, Gullick WJ. Type 1 growth factor receptors: an overview of recent developments. Breast 1995;4:11-18.
7. Riese DJ, Stern DF. Specificity within the EGF family/ErbB receptor family signaling network. BioEssays 1998;20:41-48.
8. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, Yarden Y. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 1996;16:5276-5287.
9. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 1996;15: 254-264.
10. Alroy I, Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 1997;410:83-86.
11. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. ErbB-2: the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 1997;16:1647-1655.
12. Beerli RR, Hynes NE. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 1996;271:6071-6076.
13. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 1997;16:1268-1278.
14. Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J 1997;16:4938-4950.
15. Alimandi M, Wang L-M, Bottaro D, Lee C-C, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J 1997;16:5608-5617.
16. Liscia DS, Merlo G, Ciardiello F, Kim N, Smith GH, Callahan R, Salomon DS. Transforming growth factor-α messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. Dev Biol 1990;140:123-131.
17. Snedeker SM, Brown CF, DiAugustine RP. Expression and functional properties of transforming growth factor α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA 1992;88:276-280.
18. Soriano JV, Pepper MS, Orci L, Montesanno R. Roles of hepatocyte growth factor/scatter factor and transforming growth factor-β1 in mammary gland ductal morphogenesis. J Mamm Gland Biol Neoplasia 1998;3:133-150.
19. Yi ES, Bedoya AA, Lee H, Kim S, Housley RM, Aukerman SL, Tarpley JE, Starnes C, Yin S, Pierce GF, et al. Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, estrogen and progesterone in vivo. Am J Pathol 1994;145: 1015-1022.
20. LeRoith D, Neuenschwander S, Wood TL, Henninghausen L. Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 inhibit involution of the mammary gland following lactation: studies in transgenic mice. Prog Growth Factor Res 1995;6:433-436.
21. Kenney NJ, Huang R-P, Johnson GR, Wu J-X, Okamura D, Matheny W, Kordon E, Gullick WJ, Plowman G, Smith GH, Salomon DS, Adamson ED. Detection and location of amphiregulin and cripto-1 expression in the developing postnatal mouse mammary gland. Mol Reprod Dev 1995;41: 277-286.
22. Herrington EE, Ram TG, Salomon DS, Johnson GR, Gullick WJ, Kenney N, Hosick HL. Expression of epidermal growth factor-related porteins in the aged adult mouse mammary gland and their relationship to tumorigenesis. J Cell Physiol 1997;170:47-56.
23. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 1995;131:215-226.
24. Vonderhaar BK. Regulation of development of the normal mammary gland by hormones and growth factors. In: Lippman ME, Dickson RB, editors. Breast cancer: cellular and molecular biology. Boston: KAP; 1988. p 251-266.
25. Daniel CW, Silberstein GB. Local effects of growth factors. In: Lippman ME, Dickson RB, editors. Regulatory mechanisms in breast cancer. Boston: KAP; 1991. p 79-93.
26. Kenney NJ, Smith GH, Rosenberg K, Cutler ML, Dickson RB. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Diff 1996;7:1769-1781.
27. Jones FE, Jerry DJ, Guarino BC, Andrews GC, Stern DF. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Diff 1996;7:1031-1038.
28. Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol 1997;11:1766-1781.
29. Lin CQ, Dempsey PJ, Coffey RJ, Bissell MJ. Extracellular matrix regulates whey acidic protein gene expression by suppression of transforming growth factor-α in mouse mammary epithelial cells: studies in culture and in transgenic mice. J Cell Biol 129;1995:1115-1126.
30. Spitzer E, Zschiesche W, Binas B, Grosse R, Erdmann B. Epidermal growth factor and transforming growth factor-α modulate structural and functional differentiation of the mammary gland from pregnant mice in vitro: possible role of the arachidonic acid pathway. J Cell Biochem 1995;57:495-508.
31. Normanno N, Qi C-F, Gullick WJ, Persico G, Yarden Y, Wen D, Plowman G, Kenney N, Johnson G, Kim N, Brandt R, Martinez-Lacaci I, Dickson RB, Salomon DS. Expression of amphiregulin, cripto-1, and heregulin in human breast cancer cells. Int J Oncol 1993;2:903-911.
32. Qi C-F, Liscia DS, Normanno N, Merlo G, Johnson GR, Gullick WJ, Ciardiello F, Saeki T, Brandt R, Kim N, Kenney N, Salomon DS. Expression of transforming growth factor α. amphiregulin and cripto-1 in human breast carcinoma. Br J Cancer 1994;69:903-910.
33. Panico L, DAntonio A, Salvatore G, Mezza E, Tortora G, De Laurentiis M, De Placido S, Giordano T, Merino M, Salomon DS, Gullick WJ, Pettinato G, Schnitt SJ, Bianco AR, Ciardiello F. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and cripto in human normal and malignant breast tissues. Int J Cancer 1996;65:51-56.
34. Normanno N, Ciardiello F, Brandt R, Salomon DS. Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 1994;29:11-27.
35. Nicholson RI, Gee JMW, Harper ME, Ellis IO, Willsher P, Robertson JFR. erbB signalling in clinical breast cancer: relationship to endocrine sensitivity. Endocrine Rel Cancer 1997;4:297-305.
36. Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1994;1198:165-184.
37. Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G. Transforming growth factor-α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol 1995;147: 1081-1096.
38. Krane IM, Leder P. NDF/heregulm induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 1996;12:1781-1788.
39. Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff RD, Meise KS, Li F, Halter SA, Coffey RJ. Synergistic interaction of the neu proto-oncogene product and transforming growth factor α in the mammary epithelium of transgenic mice. Mol Cell Biol 1996;16:5726-5736.
40. Normanno N, Selvan MP, Saeki T, Johnson G, Brandt R, Kim N, Ciardiello F, Shoyab M, Plowman G, Todaro G, Salomon DS. Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erb B-2 transformed human mammary epithelial cells. Proc Natl Acad Sci USA 1994;91:2790-2794.
41. Mincione G, Bianco C, Kannan S, Colletta G, Ciardiello F, Sliwkowski M, Yarden Y, Normanno N, Pramaggiore A, Kim N, Salomon DS. Enhanced expression of heregulin in c-erb B-2 and c-Ha-ras transformed mouse and human mammary epithelial cells. J Cell Biochem 1996;60:437-446.
42. Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG. Molecular characterization of a gene of the EGF family expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 1989;8: 1987-1991.
43. Dono R, Scalera L, Pacifico F, Acampora D, Persico MG, Simeone A. The murine cripto gene: expression during mesoderm induction and early heart morphogenesis. Development 1993;118:1157-1168.
44. Saccone S, Rapisarda A, Motta S, Dono R, Persico GM, Della Valle G. Regional localization of the human EGF-like growth factor CRIPTO gene (TDGF-1) to chromosome 3p21. Hum Genet 1995;95:229-230.
45. Todd MC, Xiang R-H, Garcia DK, Kerbacher KE, Moore SL, Hensel CH, Liu P, Siciliano MJ, Kok K, van den Berg A, Veldhuis P, Buys CHCM, Killary AM, Naylor SL. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 1996;13:2387-2396.
46. Dono R, Montuori N, Rocchi M, De Ponti-Zilli L, Ciccodicola A, Persico MG. Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. Am J Hum Genet 1991;49:555-565.
47. Liguori G, Tucci M, Montuori N, Dono R, Lago CT, Pacifico F, Armenante F, Persico MG. Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes. Mamm Genome 1996;7:344-348.
48. Brandt R, Normanno N, Gullick WJ, Lin J-H, Harkins R, Schenider D, Wallace-Jones B, Ciardiello F, Persico MG, Armenante F, Kim N, Salomon DS. Identification and biological characterization of an epidermal growth factor-related protein: Cripto-1. J Biol Chem 1994;269:17320-17328.
49. Kenney NJ, Smith GH, Maroulakou IG, Green JH, Muller WJ, Callahan R, Salomon DS, Dickson RB. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol Carcinogen 1996;15:44-56.
50. Shen MM, Wang H, Leder P. A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation. Development 1997;124:429-442.
51. Kinoshita N, Minshull J, Kirschner MW. The identification of two novel ligands of the FGF receptor by a yeast screening method and their activity in Xenopus development. Cell 1995;83:621-630.
52. Zhang J, Talbot WS, Schier AF. Positional cloning identifies zebrafish one-eyed pinhead as a permissive EGF-related ligand required during gastrulation. Cell 1998;92:241-251.
53. Johnson SE, Rothstein JL, Knowles BB. Expression of epidermal growth factor family gene members in early mouse development. Dev Dynam 1994;201:216-226.
54. Baldassare G, Romano A, Armenante F, Rambaldi M, Paoletti I, Sandomenico C, Pepe S, Staibano S, Salvatore G, De Rosa G, Persico MG, Viglietto G. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene 1997;15:927-936.
55. Xu C, Liguori G, Adamson ED, Persico MG. Specific arrest of cardiogenesis in cultured embryonic stem cells lacking cripto-1. Dev Biol 1998;196: 237-247.
56. Seno M, De Santis M, Kannan S, Bianco C, Tada H, Kim N, Kosaka M, Gullick WJ, Yamada H, Salomon DS. Purification and characterization of a recombinant human cripto-1 protein. Growth Factors 1998;15:215-229.
57. Kannan S, De Santis M, Lohmeyer M, Riese DJ II, Smith GH, Hynes N, Seno M, Brandt R, Bianco C, Persico G, Kenney N, Normanno N, Martinez-Lacaci I, Ciardiello F, Stern DF, Gullick WJ, Salomon DS. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem 1997;272:3330-3335.
58. ras-and phosphatidylinositol-3 kinase-dependent pathway. Cell Growth Diff 1997; 8:1257-1266.
59. Kenney NJ, Hosick H, Herrington E, Smith GH.. The aged mammary gland. In: Mohr U, Dungworth DL, Capen CC, Carlton WW, Sundberg JP, Ward JM, editors. Pathobiology of the aging mouse Vol 2. Washington. DC: ISLI Press; 1997. p 369-379.
60. Ciardiello F, Dono R, Kim N, Persico MG, Salomon DS. Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res 1991;51:1051-1054.
61. Niemeyer CC, Persico MG, Adamson ED. Cripto: roles in mammary cell growth, survival, differentiation and transformation. Cell Death Diff 1998;5: 440-449.
62. Su Z-Z, Austin VN, Zimmer SG, Fisher PB. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 1993;8:1211-1219.
63. Kenney NJ, Smith GH, Johnson MD, Rosenberg K, Salomon DS, Dickson RB. Cripto-1 activity in the intact and ovariectomized virgin mouse mammary gland. Pathogenesis 1997;1:57-71.
64. Soriano JV, Pepper MS, Nakamura T, Orci L, Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci 1995;108: 413-430.
65. Sastry SK, Horwitz AF, Adhesion-growth factor interactions during differentiation: an integrated biological response. Dev Biol 1996;180:455-467.
66. Merlo GR, Graus-Porta D, Cella N, Marte BM, Taverna D, Hynes NE. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors. Eur J Cell Biol 1996;70:97-105.
67. Groner B, Gouilleux F. Prolactin-mediated gene activation in mammary epithelial cells. Curr Opin Gen Dev 1995;5:587-594.
68. Normanno N, Kim N, Wen D, Smith K, Harris AL, Plowman G, Colletta G, Ciardiello F, Salomon DS. Expression of messenger RNA for amphiregulin, heregulin and cripto-1: three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res Treat 1995;35:293-297.
69. Dublin EA, Bobrow LG, Barnes DM, Gullick WJ. Amphiregulin and cripto overexpression in breast cancer: relationship with prognosis and clinical and molecular variables. Int J Oncol 1995;7:617-622.
70. Castellino AM, Chao MV. Trans-signaling by cytokine and growth factor receptors. Cytokine Growth Factor Rev 1996;7:297-302.
71. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature 1996;382:80-82.